Our Sustainability key indicators
Strategic Goal | Value chain | Sustainability key indicator | 2024 | 2023 | More information | |||||
---|---|---|---|---|---|---|---|---|---|---|
1 | Own operations | Percentage of newly published patent families with positive sustainability impact | 34 | 29 | – | |||||
1 | Downstream | Number of people treated with our Healthcare products (in million) | 184 | 177 | S4 | |||||
1 | Downstream | Number of people treated with pharmaceutical products enabled by our Life Science business sector (in million) | 424 | 310 | – | |||||
2 | Own operations | Result of the Employee Engagement Survey on sustainability culture | not published | not published | G1 | |||||
2 | Own operations | Percentage of women in leadership positions | 39 | 39 | S1 | |||||
2 | Own operations | Environment, health and safety (EHS) incident rate | 2.2 | 2.4 | S1 | |||||
2 | Own operations | Lost time injury rate (LTIR) | 1.2 | 1.3 | S1 | |||||
Upstream | Percentage of relevant suppliers (in terms of number) that are covered by a valid sustainability assessment | 75 | 66 | S2 | ||||||
2 | Upstream | Percentage of relevant suppliers (in terms of spend) that are covered by a valid sustainability assessment | 94 | 94 | S2 | |||||
2 | Own operations | Violations of Global Social and Labor Standards Policy | 57 | 60 | S1 | |||||
3 | Own operations | Greenhouse gas emissions Scope 1 and 2 (in metric tons) | 1,085,124 | 1,463,000 | E1 | |||||
3 | Upstream; downstream | Indirect greenhouse gas emissions (Scope 3 intensity: metric tons CO2eq per € million gross profit) | 359 | 371 | E1 | |||||
3 | Upstream | Percentage of purchased electricity from renewable sources | 52 | 51 | E1 | |||||
3 | Own operations | Circularity rate (in %) | 69.2 | 67.8 | E5 | |||||
3 | Own operations | Water efficiency (m3 per € million net sales) | 588 | 576 | E3 |